feed,title,long_url,short_url
Benzinga,Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug,https://benzinga.com/general/biotech/22/11/29651324/veru-stock-could-retrace-weeks-45-gain-as-fda-panel-votes-against-covid-19-drug,https://bit.ly/3G4LK4S
